These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18234298)

  • 1. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nasu K; Narahara H
    Gynecol Oncol; 2008 Nov; 111(2):336-43. PubMed ID: 18790523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neoplastic effect of β-hydroxyisovalerylshikonin on a human choriocarcinoma cell line.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Mol Med Rep; 2010; 3(3):515-8. PubMed ID: 21472272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
    Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
    Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
    Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2010 Jan; 25(1):97-103. PubMed ID: 19956907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Mol Med Rep; 2010; 3(3):479-84. PubMed ID: 21472266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1).
    Masuda Y; Nishida A; Hori K; Hirabayashi T; Kajimoto S; Nakajo S; Kondo T; Asaka M; Nakaya K
    Oncogene; 2003 Feb; 22(7):1012-23. PubMed ID: 12592388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
    Ishii T; Kira N; Yoshida T; Narahara H
    Tumour Biol; 2013 Feb; 34(1):285-91. PubMed ID: 23150173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
    Takai N; Narahara H
    Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
    Takai N; Ueda T; Kawano Y; Nishida M; Nasu K; Narahara H
    Oncol Rep; 2005 Nov; 14(5):1287-91. PubMed ID: 16211298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells.
    Fan L; Ma Y; Liu Y; Zheng D; Huang G
    Eur J Pharmacol; 2014 Nov; 743():79-88. PubMed ID: 25242120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY; Jung JH; Na YJ; Kim HS
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.